This page is part of the FHIR Specification (v3.0.2: STU 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Ballot Status: Informative | Compartments: Patient, Practitioner |
Dispense for Brentuximab Vedotin (NDC code) - IV Chemo - stopped
{ "resourceType": "MedicationDispense", "id": "meddisp0317", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: meddisp0317</p><p><b>contained</b>: </p><p><b>status</b>: stopped</p><p><b>medication</b>: Brentixumab Vedotin (Adcetris). Generated Summary: id: med0306; Adcetris (Brentuximab Vedotin 50mg/10.5ml) <span>(Details : {http://hl7.org/fhir/sid/ndc code '51144-050-01' = '51144-050-01', given as 'Adcetris (Brentuximab Vedotin 50mg/10.5ml)'})</span>; isBrand; Lyophilized powder for injectable solution (qualifier value) <span>(Details : {SNOMED CT code '421637006' = 'Lyophilised powder for injectable solution', given as 'Lyophilized powder for injectable solution (qualifier value) '})</span></p><p><b>subject</b>: <a>Donald Duck </a></p><h3>Performers</h3><table><tr><td>-</td><td><b>Actor</b></td><td><b>OnBehalfOf</b></td></tr><tr><td>*</td><td><a>Practitioner/f006</a></td><td><a>Organization/2.16.840.1.113883.19.5</a></td></tr></table><p><b>authorizingPrescription</b>: <a>MedicationRequest/medrx0316</a></p><p><b>type</b>: Trial Fill <span>(Details : {http://hl7.org/fhir/v3/ActCode code 'TF' = 'Trial Fill', given as 'Trial Fill'})</span></p><p><b>quantity</b>: 3 415818005<span> (Details: SNOMED CT code 415818005 = '415818005')</span></p><p><b>daysSupply</b>: 1 Day<span> (Details: UCUM code d = 'd')</span></p><p><b>whenPrepared</b>: 25/06/2015 7:13:00 AM</p><p><b>whenHandedOver</b>: 26/06/2015 7:13:00 AM</p><p><b>dosageInstruction</b>: </p></div>" }, "contained": [ { "resourceType": "Medication", "id": "med0306", "code": { "coding": [ { "system": "http://hl7.org/fhir/sid/ndc", "code": "51144-050-01", "display": "Adcetris (Brentuximab Vedotin 50mg/10.5ml)" } ] }, "isBrand": true, "manufacturer": { "reference": "Organization/mmanu" }, "form": { "coding": [ { "system": "http://snomed.info/sct", "code": "421637006", "display": "Lyophilized powder for injectable solution (qualifier value) " } ] }, "package": { "batch": [ { "lotNumber": "12345", "expirationDate": "2019-10-31" } ] } } ], "status": "stopped", "medicationReference": { "reference": "#med0306", "display": "Brentixumab Vedotin (Adcetris)" }, "subject": { "reference": "Patient/pat1", "display": "Donald Duck " }, "performer": [ { "actor": { "reference": "Practitioner/f006" }, "onBehalfOf": { "reference": "Organization/2.16.840.1.113883.19.5" } } ], "authorizingPrescription": [ { "reference": "MedicationRequest/medrx0316" } ], "type": { "coding": [ { "system": "http://hl7.org/fhir/v3/ActCode", "code": "TF", "display": "Trial Fill" } ] }, "quantity": { "value": 3, "system": "http://snomed.info/sct", "code": "415818005" }, "daysSupply": { "value": 1, "unit": "Day", "system": "http://unitsofmeasure.org", "code": "d" }, "whenPrepared": "2015-06-25T07:13:00+05:00", "whenHandedOver": "2015-06-26T07:13:00+05:00", "dosageInstruction": [ { "sequence": 1, "text": "1.8 mg/kg IV infusion over 30 minutes every 3 weeks for 16 cycles", "timing": { "repeat": { "count": 16, "frequency": 1, "period": 3, "periodUnit": "wk" } }, "route": { "coding": [ { "system": "http://snomed.info/sct", "code": "255560000", "display": "Intravenous" } ] }, "doseQuantity": { "value": 1.8, "unit": "mg/kg", "system": "http://unitsofmeasure.org", "code": "mg/kg" } } ] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.